Investment Thesis — Option Care Health, Inc.
The market underappreciates Option Care Health’s ability to leverage its scale and payer relationships to drive margin expansion in a fragmented infusion services market. Investors are anchored to historical low returns and overlook the inflection point as hospital systems outsource more complex care, shifting profit pools to specialized providers like OPCH.
Catalysts
- Major payer contract wins or renewals on favorable terms
- Hospital system partnerships accelerating infusion outsourcing
- Margin expansion from operational leverage and higher-acuity mix
Risk Factors
- Reimbursement cuts or regulatory headwinds
- Slower-than-expected adoption of home infusion by hospitals
- Execution missteps leading to operational or integration issues
Key Debates
5.2% Fwd Rev Growth Reaccelerates by Q1, Rerating P/E to 20x
Analyst Target $38.14 Reached by Q3 on Short Squeeze
P/E Multiple Expands to 18x by H2 on Margin Improvement